CD36 and breast cancer: However in breast cancers, it is the elevated expression of FABP5 rather than CD36 or FABP4 that play critical roles in acceleration of FA trafficking and nuclear activation of PPARγ, along with induction of lipolysis and ATGL-mediated utilization of accumulated lipids (4).